BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 1451952)

  • 1. Life table analysis of the risk of type 1 (insulin-dependent) diabetes mellitus in siblings according to islet cell antibodies and HLA markers. An 8-year prospective study.
    Deschamps I; Boitard C; Hors J; Busson M; Marcelli-Barge A; Mogenet A; Robert JJ
    Diabetologia; 1992 Oct; 35(10):951-7. PubMed ID: 1451952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
    Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
    J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early onset of diabetes in the proband is the major determinant of risk in HLA DR3-DQ2/DR4-DQ8 siblings.
    Gillespie KM; Aitken RJ; Wilson I; Williams AJ; Bingley PJ
    Diabetes; 2014 Mar; 63(3):1041-7. PubMed ID: 24203724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of human leukocyte antigen class II typing for the development of islet autoantibodies and insulin-dependent diabetes postpartum in women with gestational diabetes.
    Ferber KM; Keller E; Albert ED; Ziegler AG
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2342-8. PubMed ID: 10404800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutamic acid decarboxylase antibodies in relation to other autoantibodies and genetic risk markers in children with newly diagnosed insulin-dependent diabetes. Childhood Diabetes in Finland Study Group.
    Sabbah E; Kulmala P; Veijola R; Vähäsalo P; Karjalainen J; Tuomilehto-Wolf E; Akerblom HK; Knip M
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2455-9. PubMed ID: 8675560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Islet cell and insulin autoantibodies in subjects at high risk for development of type 1 (insulin-dependent) diabetes mellitus: the Lyon family study.
    Thivolet C; Beaufrére B; Bétuel H; Gebuhrer L; Chatelain P; Durand A; Tourniaire J; François R
    Diabetologia; 1988 Oct; 31(10):741-6. PubMed ID: 3071483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific association of HLA-DR4 with increased prevalence and level of insulin autoantibodies in first-degree relatives of patients with type I diabetes.
    Ziegler R; Alper CA; Awdeh ZL; Castano L; Brink SJ; Soeldner JS; Jackson RA; Eisenbarth GS
    Diabetes; 1991 Jun; 40(6):709-14. PubMed ID: 2040387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Millennium award recipient contribution. Identification of children with early onset and high incidence of anti-islet autoantibodies.
    Robles DT; Eisenbarth GS; Wang T; Erlich HA; Bugawan TL; Babu SR; Barriga K; Norris JM; Hoffman M; Klingensmith G; Yu L; Rewers M;
    Clin Immunol; 2002 Mar; 102(3):217-24. PubMed ID: 11890708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homozygosity for premature stop codon of the MHC class I chain-related gene A (MIC-A) is associated with early activation of islet autoimmunity of DR3/4-DQ2/8 high risk DAISY relatives.
    Ide A; Babu SR; Robles DT; Wang T; Erlich HA; Bugawan TL; Rewers M; Fain PR; Eisenbarth GS
    J Clin Immunol; 2005 Jul; 25(4):303-8. PubMed ID: 16133985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology and inmunogenetics in recently diagnosed Venezuelan children with insulin-dependent diabetes mellitus.
    Gunczler P; Lanes R; Layrisse Z; Esparza B; Salas R; Hernández L; Arnaiz-Villena A
    J Pediatr Endocrinol; 1993; 6(2):165-71. PubMed ID: 8394177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organ-specific autoimmunity and HLA-DR antigens as markers for beta-cell destruction in patients with type II diabetes.
    Groop L; Miettinen A; Groop PH; Meri S; Koskimies S; Bottazzo GF
    Diabetes; 1988 Jan; 37(1):99-103. PubMed ID: 3275559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic markers, humoral autoimmunity, and prediction of type 1 diabetes in siblings of affected children. Childhood Diabetes in Finland Study Group.
    Kulmala P; Savola K; Reijonen H; Veijola R; Vähäsalo P; Karjalainen J; Tuomilehto-Wolf E; Ilonen J; Tuomilehto J; Akerblom HK; Knip M
    Diabetes; 2000 Jan; 49(1):48-58. PubMed ID: 10615949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [HLA-antigens and islet cell antibodies in type-1 diabetics of various age groups and their first-degree relatives].
    Spinas GA; Keller U; Neri TM; Matter L; Staffelbach O; Berger W
    Schweiz Med Wochenschr; 1985 Jan; 115(2):48-54. PubMed ID: 3881821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Islet cell autoimmunity and progression to insulin-dependent diabetes mellitus in genetically high- and low-risk siblings of diabetic children. The Childhood Diabetes in Finland (DiMe) Study Group.
    Karjalainen J; Vähasalo P; Knip M; Tuomilehto-Wolf E; Virtala E; Akerblom HK
    Eur J Clin Invest; 1996 Aug; 26(8):640-9. PubMed ID: 8872058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevalence and predictive value of GAD65 autoantibodies and their correlation with HLA DR-DQ genotypes in children with type-1 diabetes].
    Hermann R; Gombos Z; Gyürüs E; Soltész G
    Orv Hetil; 2003 Feb; 144(8):355-60. PubMed ID: 12666382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extreme genetic risk for type 1A diabetes.
    Aly TA; Ide A; Jahromi MM; Barker JM; Fernando MS; Babu SR; Yu L; Miao D; Erlich HA; Fain PR; Barriga KJ; Norris JM; Rewers MJ; Eisenbarth GS
    Proc Natl Acad Sci U S A; 2006 Sep; 103(38):14074-9. PubMed ID: 16966600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-associated insulin autoantibody formation in newly diagnosed type I diabetic patients.
    Ziegler AG; Standl E; Albert E; Mehnert H
    Diabetes; 1991 Sep; 40(9):1146-9. PubMed ID: 1936622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late-onset islet autoimmunity in childhood: the Diabetes Autoimmunity Study in the Young (DAISY).
    Frohnert BI; Ide L; Dong F; Barón AE; Steck AK; Norris JM; Rewers MJ
    Diabetologia; 2017 Jun; 60(6):998-1006. PubMed ID: 28314946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excess of maternal HLA-DR3 antigens in HLA DR3,4 positive type 1 (insulin-dependent) diabetic patients.
    Deschamps I; Hors J; Clerget-Darpoux F; Gardais E; Robert JJ; Marcelli-Berge A; Lestradet H; Dausset J
    Diabetologia; 1990 Jul; 33(7):425-30. PubMed ID: 2401398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of families at risk for insulin-dependent diabetes mellitus reveals that HLA antigens influence progression to clinical disease.
    Honeyman MC; Harrison LC; Drummond B; Colman PG; Tait BD
    Mol Med; 1995 Jul; 1(5):576-82. PubMed ID: 8529124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.